Safety, Tolerability, and Efficacy of Fasudil in Amyotrophic Lateral Sclerosis (ROCK-ALS): a Phase 2, Randomised, Double-Blind, Placebo-Controlled Trial Jan C. Koch , Andreas Leha , Helen Bidner , Isabell Cordts , Johannes Dorst , Rene Gunther , Daniel Zeller , Nathalie Braun , Moritz Metelmann , Philippe Corcia , Elisa de la Cruz , Patrick Weydt , Thomas Meyer , Julian Grosskreutz , Marie-Helene Soriani , Shahram Attarian , Jochen H. Weishaupt , Ute Weyen , Josua Kuttler , Gabriela Zurek , Mary-Louise Rogers , Emily Feneberg , Marcus Deschauer , Christoph Neuwirth , Joanne Wuu , Albert C. Ludolph , Jens Schmidt , Yvonne Remane , William Camu , Tim Friede , Michael Benatar , Markus Weber , Paul Lingor LANCET NEUROLOGY（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
